Imaging of SHOX-Associated Anomalies

ABSTRACT

Human growth is a multifactorial trait influenced by environmental, hormonal, and genetic factors. Although it is clear that multiple factors contribute to an individual's final height and limb development, genetic factors play a crucial role. One such gene is the short stature homeobox (SHOX) containing gene. Knowledge about the SHOX gene has rapidly increased since its discovery in 1997, and we now know that SHOX haploinsufficiency affects the development of the extremities and is an important cause of short stature. Currently, SHOX mutations occur with an estimated incidence of roughly 1 in 1000 newborns, making mutations of this gene one of the most common genetic defects associated with growth failure and skeletal deformities. Heterozygous mutations of SHOX have been implicated in patients with Madelung's deformity, Leri-Weill dyschondrosteosis (77%), Turner's syndrome (66%), and idiopathic short stature (3%), and homozygous mutations of SHOX gene have been identified in patients with Langer's mesomelic dysplasia (100%). Recognition of the early radiographic features encountered in SHOX haploinsufficiency maybe pivotal for the diagnosis. In this article, we summarize the genetic and clinical features of the various SHOX haploinsufficiency-associated disorders. We present the characteristic imaging features of these disorders and the results of growth hormone treatment trials.

KEYWORDS

SHOX gene - Langer's mesomelic dysplasia - Leri-Weill dyschondrosteosis - Madelung's deformity - idiopathic short stature - Turner's syndrome

REFERENCES

• 1 Rao E, Weiss B, Fukami M et al.. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome.  Nat Genet. 1997;  16(1) 54-63
• 2 Ellison J W, Wardak Z, Young M F, Gehron Robey P, Laig-Webster M, Chiong W. PHOG, a candidate gene for involvement in the short stature of Turner syndrome.  Hum Mol Genet. 1997;  6(8) 1341-1347
• 3 Leka S K, Kitsiou-Tzeli S, Kalpini-Mavrou A, Kanavakis E. Short stature and dysmorphology associated with defects in the SHOX gene.  Hormones (Athens). 2006;  5(2) 107-118
• 4 Clement-Jones M, Schiller S, Rao E et al.. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome.  Hum Mol Genet. 2000;  9(5) 695-702
• 5 Munns C J, Haase H R, Crowther L M et al.. Expression of SHOX in human fetal and childhood growth plate.  J Clin Endocrinol Metab. 2004;  89(8) 4130-4135
• 6 Marchini A, Marttila T, Winter A et al.. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes.  J Biol Chem. 2004;  279(35) 37103-37114
• 7 Grigelioniene G, Eklöf O, Ivarsson S A et al.. Mutations in short stature homeobox containing gene (SHOX) in dyschondrosteosis but not in hypochondroplasia.  Hum Genet. 2000;  107(2) 145-149
• 8 Tiecke E, Bangs F, Blaschke R, Farrell E R, Rappold G, Tickle C. Expression of the short stature homeobox gene SHOX is restricted by proximal and distal signals in chick limb buds and affects the length of skeletal elements.  Dev Biol. 2006;  298(2) 585-596
• 9 Shears D J, Vassal H J, Goodman F R et al.. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis.  Nat Genet. 1998;  19(1) 70-73
• 10 Belin V, Cusin V, Viot G et al.. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).  Nat Genet. 1998;  19(1) 67-69
• 11 Huber C, Cusin V, Le Merrer M et al.. SHOX point mutations in dyschondrosteosis.  J Med Genet. 2001;  38(5) 323
• 12 Shears D J, Guillen-Navarro E, Sempere-Miralles M, Domingo-Jimenez R, Scambler P J, Winter R M. Pseudodominant inheritance of Langer mesomelic dysplasia caused by a SHOX homeobox missense mutation.  Am J Med Genet. 2002;  110(2) 153-157
• 13 Zinn A R, Wei F, Zhang L et al.. Complete SHOX deficiency causes Langer mesomelic dysplasia.  Am J Med Genet. 2002;  110(2) 158-163
• 14 Robertson S P, Shears D J, Oei P et al.. Homozygous deletion of SHOX in a mentally retarded male with Langer mesomelic dysplasia.  J Med Genet. 2000;  37(12) 959-964
• 15 Schiller S, Spranger S, Schechinger B et al.. Phenotypic variation and genetic heterogeneity in Léri-Weill syndrome.  Eur J Hum Genet. 2000;  8(1) 54-62
• 16 Blanco M E, Pérez-Cabrera A, Kofman-Alfaro S, Zenteno J C. Clinical and cytogenetic findings in 14 patients with Madelung anomaly.  Orthopedics. 2005;  28(3) 315-319
• 17 Langer Jr L O. Dyschondrosteosis, a heritable bone dysplasia with characteristic roentgenographic features.  Am J Roentgenol Radium Ther Nucl Med. 1965;  95 178-188
• 18 Binder G, Ranke M B, Martin D D. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature.  J Clin Endocrinol Metab. 2003;  88(10) 4891-4896
• 19 Huber C, Rosilio M, Munnich A, Cormier-Daire V. French SHOX GeNeSIS Module . High incidence of SHOX anomalies in individuals with short stature.  J Med Genet. 2006;  43(9) 735-739
• 20 Binder G, Renz A, Martinez A et al.. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity.  J Clin Endocrinol Metab. 2004;  89(9) 4403-4408
• 21 Rappold G A. The pseudoautosomal regions of the human sex chromosomes.  Hum Genet. 1993;  92(4) 315-324
• 22 Ross J L, Scott Jr C, Marttila P et al.. Phenotypes associated with SHOX deficiency.  J Clin Endocrinol Metab. 2001;  86(12) 5674-5680
• 23 Evans M I, Zador I E, Qureshi F, Budev H, Quigg M H, Nadler H L. Ultrasonographic prenatal diagnosis and fetal pathology of Langer mesomelic dwarfism.  Am J Med Genet. 1988;  31(4) 915-920
• 24 Munns C F, Glass I A, LaBrom R et al.. Histopathological analysis of Leri-Weill dyschondrosteosis: disordered growth plate.  Hand Surg. 2001;  6(1) 13-23
• 25 Kosho T, Muroya K, Nagai T et al.. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome.  J Clin Endocrinol Metab. 1999;  84(12) 4613-4621
• 26 Ogata T, Matsuo N, Nishimura G. SHOX haploinsufficiency and overdosage: impact of gonadal function status.  J Med Genet. 2001;  38(1) 1-6
• 27 Fukami M, Nishi Y, Hasegawa Y et al.. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens.  Endocr J. 2004;  51(2) 197-200
• 28 Munns C F, Glass I A, Flanagan S et al.. Familial growth and skeletal features associated with SHOX haploinsufficiency.  J Pediatr Endocrinol Metab. 2003;  16(7) 987-996
• 29 Nishi M Y, Correa R V, Costa E M et al.. Tall stature and poor breast development after estrogen replacement in a hypergonadotrophic hypogonadic patient with a 45,X/46,X,der(X) karyotype with SHOX gene overdosage.  Arq Bras Endocrinol Metabol. 2008;  52(8) 1282-1287
• 30 Kanaka-Gantenbein C, Kitsiou S, Mavrou A et al.. Tall stature, insulin resistance, and disturbed behavior in a girl with the triple X syndrome harboring three SHOX genes: offspring of a father with mosaic Klinefelter syndrome but with two maternal X chromosomes.  Horm Res. 2004;  61(5) 205-210
• 31 Ogata T, Kosho T, Wakui K, Fukushima Y, Yoshimoto M, Miharu N. Short stature homeobox-containing gene duplication on the der(X) chromosome in a female with 45,X/46,X, der(X), gonadal dysgenesis, and tall stature.  J Clin Endocrinol Metab. 2000;  85(8) 2927-2930
• 32 Binder G, Eggermann T, Enders H, Ranke M B, Dufke A. Tall stature, gonadal dysgenesis, and stigmata of Turner's syndrome caused by a structurally altered X chromosome.  J Pediatr. 2001;  138(2) 285-287
• 33 Day G, Szvetko A, Griffiths L et al.. SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in Turner syndrome.  J Orthop Res. 2009;  27(6) 807-813
• 34 Ogata T, Inokuchi M, Ogawa M. Growth pattern and body proportion in a female with short stature homeobox-containing gene overdosage and gonadal estrogen deficiency.  Eur J Endocrinol. 2002;  147(2) 249-254
• 35 Goldblatt J, Wallis C, Viljoen D, Beighton P. Heterozygous manifestations of Langer mesomelic dysplasia.  Clin Genet. 1987;  31(1) 19-24
• 36 Rappold G, Blum W F, Shavrikova E P et al.. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency.  J Med Genet. 2007;  44(5) 306-313
• 37 Shanske A L, Puri M, Marshall B, Saenger P. Unique deletion in exon 5 of SHOX gene in a patient with idiopathic short stature.  Horm Res. 2007;  67(2) 61-66
• 38 Hintz R L. SHOX mutations.  Rev Endocr Metab Disord. 2002;  3(4) 363-367
• 39 Langer Jr L O. Mesomelic dwarfism of the hypoplastic ulna, fibula, mandible type.  Radiology. 1967;  89(4) 654-660
• 40 Espiritu C, Chen H, Woolley Jr P VJ. Mesomelic dwarfism as the homozygous expression of dyschondrosteosis.  Am J Dis Child. 1975;  129(3) 375-377
• 41 Baxova A, Kozlowski K, Netriova I, Sillence D. Mesomelic dysplasia: Langer type.  Australas Radiol. 1994;  38(1) 58-60
• 42 Kunze J, Klemm T. Mesomelic dysplasia, type Langer—a homozygous state for dyschondrosteosis.  Eur J Pediatr. 1980;  134(3) 269-272
• 43 Balci S, Zafer Y, Unsal M. Two female siblings from Turkey with Langer mesomelic dysplasia (homozygous Leri-Weill dyschondrosteosis syndrome).  Turk J Pediatr. 1999;  41(4) 531-539
• 44 Fukami M, Okuyama T, Yamamori S, Nishimura G, Ogata T. Microdeletion in the SHOX 3′ region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri-Weill dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer.  Am J Med Genet A. 2005;  137(1) 72-76
• 45 Benito-Sanz S, Thomas N S, Huber C et al.. A novel class of pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.  Am J Hum Genet. 2005;  77(4) 533-544 , Erratum: Am J Hum Genet 2005;77(6):1131
• 46 Kantaputra P N, Gorlin R J, Langer Jr L O. Dominant mesomelic dysplasia, ankle, carpal, and tarsal synostosis type: a new autosomal dominant bone disorder.  Am J Med Genet. 1992;  44(6) 730-737
• 47 Roth P, Agnani G, Arbez-Gindre F, Maillet R, Colette C. Langer mesomelic dwarfism: ultrasonographic diagnosis of two cases in early mid-trimester.  Prenat Diagn. 1996;  16(3) 247-251
• 48 Leri A, Weill J. Une affection congenitale et symétrique du dévelopement osseux: la dyschondrosteose.  Bull Mem Soc Med Hop Paris. 1929;  53 1491-1494
• 49 Rappold G A, Fukami M, Niesler B et al.. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.  J Clin Endocrinol Metab. 2002;  87(3) 1402-1406
• 50 Carter P R, Ezaki M. Madelung's deformity. Surgical correction through the anterior approach.  Hand Clin. 2000;  16(4) 713-721 x-xi
• 51 Sabherwal N, Schneider K U, Blaschke R J, Marchini A, Rappold G. Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome.  J Cell Sci. 2004;  117(Pt 14) 3041-3048
• 52 Jorge A A, Souza S C, Nishi M Y et al.. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.  Clin Endocrinol (Oxf). 2007;  66(1) 130-135
• 53 Berdon W E, Grossman H, Baker D H. Dyschondrostéose (Leri-Weill syndrome): congenital short forearms, Madelung-type wrist deformities, and moderate dwarfism.  Radiology. 1965;  85(4) 677-681
• 54 Binder G, Fritsch H, Schweizer R, Ranke M B. Radiological signs of Leri-Weill dyschondrosteosis in Turner syndrome.  Horm Res. 2001;  55(2) 71-76
• 55 Madelung V. Die spontane Subluxation der Hand nach Vorne.  Arch Klin Chir. 1878;  23 395-412
• 56 Jobe M T, Wright P EI. Congenital anomalies of hand. In: Canale T Campbell's Operative Orthopaedics. 9th ed. St. Louis, MO; Mosby 1998: 3816-3818
• 57 Flanagan S F, Munns C F, Hayes M et al.. Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood.  J Med Genet. 2002;  39(10) 758-763
• 58 Dannenberg M, Anton J, Spiegel M. Madelung's deformity—consideration of its roentgenological diagnostic criteria.  Am J Roentgen Radium Ther Nucl Med. 1939;  42(5) 671-676
• 59 Anton J I, Reitz G B, Spiegel M B. Madelung's deformity.  Ann Surg. 1938;  108(3) 411-439
• 60 Lamberti P M, Light T R. Madelung deformity. 2008: 1-29 Available at: http://emedicine.medscape.com/article/1260002
• 61 Zebala L P, Manske P R, Goldfarb C A. Madelung's deformity: a spectrum of presentation.  J Hand Surg [Am]. 2007;  32(9) 1393-1401
• 62 Plafki C, Luetke A, Willburger R E, Wittenberg R H, Steffen R. Bilateral Madelung's deformity without signs of dyschondrosteosis within five generations in a European family—case report and review of the literature.  Arch Orthop Trauma Surg. 2000;  120(1-2) 114-117
• 63 Wit J M, Clayton P E, Rogol A D, Savage M O, Saenger P H, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation.  Growth Horm IGF Res. 2008;  18(2) 89-110
• 64 Diago Cabezudo J I, Carrascosa Lezcano A, del Valle Núñez C J, Ferrández Longás A, Gracia Bouthelier R, Pombo Arias M. Idiopathic short stature: definition and treatment [in Spanish].  An Pediatr (Barc). 2006;  64(4) 360-364
• 65 Savage M O, Camacho-Hübner C, David A et al.. Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?.  Eur J Endocrinol. 2007;  157(suppl 1) S33-S37
• 66 Binder G, Schwarze C P, Ranke M B. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.  J Clin Endocrinol Metab. 2000;  85(1) 245-249
• 67 Schneider K U, Sabherwal N, Jantz K et al.. Identification of a major recombination hotspot in patients with short stature and SHOX deficiency.  Am J Hum Genet. 2005;  77(1) 89-96
• 68 Musebeck J, Mohnike K, Beye P et al.. Short stature homeobox-containing gene deletion screening by fluorescence in situ hybridisation in patients with short stature.  Eur J Pediatr. 2001;  160(9) 561-565
• 69 Morizio E, Stuppia L, Gatta V et al.. Deletion of the SHOX gene in patients with short stature of unknown cause.  Am J Med Genet A. 2003;  119A(3) 293-296
• 70 Tan Y M, Loke K Y. Isolated haploinsufficiency of exon 1 of the SHOX gene in a patient with idiopathic short stature.  J Clin Pathol. 2006;  59(7) 773-774
• 71 Attie K M. Genetic studies in idiopathic short stature.  Curr Opin Pediatr. 2000;  12(4) 400-404
• 72 Turner H H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus.  Endocrinology. 1938;  23 566-574
• 73 Ross J L, Kowal K, Quigley C A et al.. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome.  J Pediatr. 2005;  147(4) 499-507
• 74 Schwartz R P, Sumner T E. Madelung's deformity as a presenting sign of Turner's syndrome.  J Pediatr. 2000;  136(4) 563
• 75 Blaschke R J, Rappold G A. SHOX: growth, Léri-Weill and Turner syndromes.  Trends Endocrinol Metab. 2000;  11(6) 227-230
• 76 Ogata T, Muroya K, Matsuo N et al.. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients.  J Clin Endocrinol Metab. 2001;  86(11) 5498-5508
• 77 Zinn A R. Growing interest in Turner syndrome.  Nat Genet. 1997;  16(1) 3-4
• 78 Munns C F, Berry M, Vickers D et al.. Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.  J Pediatr Endocrinol Metab. 2003;  16(7) 997-1004
• 79 Ogata T, Onigata K, Hotsubo T, Matsuo N, Rappold G. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX.  Endocr J. 2001;  48(3) 317-322
• 80 Shanske A, Ellison J, Vuguin P et al.. Deletion of the pseudoautosomal region in a male with a unique Y;13 translocation and short stature.  Am J Med Genet. 1999;  82(1) 34-39
• 81 Blum W F, Crowe B J, Quigley C A SHOX Study Group et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial.  J Clin Endocrinol Metab. 2007;  92(1) 219-228